Trial intelligence / Profile preview

Tumescent local anesthesia versus conventional lidocaine/epinephrine anesthesia for Mohs micrographic surgery

NL-OMON34466Active, not recruiting

Sponsor
Catharina Ziekenhuis
Start
Oct 2010
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised, open-label trial of lidocaine, epinephrine and bupivacaine in basal cell carcinoma (BCC) (2 arms), sponsored by Catharina Ziekenhuis. Primary endpoints: Pain perception during anesthesia, Pain during operation and 1 more. Started Oct 2010; status: active, not recruiting.

02

Drugs

lidocaineepinephrinebupivacaine
03

Conditions

basal cell carcinoma (BCC)

Beyond the preview

Go deeper on NL-OMON34466.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON34466.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call